Wanted : a postdoctoral position for the FDD. Title: Exploring the effect of photobiomodulation on brain activity using fMRI and MEG Validity: 1/01/2022 Contact: Dr Malvina Billeres – Malvina.billeres@cea.fr More details in the job description
Latest news
Read the latest news about Clinatec here.
Honda Prize 2021 : Pr. Alim Louis Benabid awarded
Awarded annually, the Honda Prize is an international distinction that highlights innovative research in environmental technologies. This year, Professor Alim-Louis Benabid will be honored for his discovery of deep brain stimulation (DBS) and its effects on the symptoms of Parkinson’s disease. Professor Benabid continues his innovative work at Clinatec, Edmond J. Safra biomedical research center. […]
Alim-Louis Benabid Honored by International Neuromodulation Society
Giant of Neuromodulation Award’ Recognizes Benabid’s Pioneering Work In Treating Symptoms of Parkinson’s Disease, Essential Tremor and Dystonia
The Breakthrough Prize
Professor Alim Louis Benabid received the Breakthrough Prize 2015 from Sergeï Brin, Google Co-Founder and Anne E. Wojcicki, scientist, sêcialized in biotechnologies and genomics.
A new prize for Pr Alim-Louis Benabid
Third Award this Year Honors His Work in Treating Parkinson’s Disease and Highlights Research at Clinatec to Treat Neurological Disorders
Clinatec Chairman Alim-Louis Benabid Wins Breakthrough Prize
First French Scientist to Win Award Says Successes Point to New Ways to Use Deep Brain Stimulation to Treat Many other Neurodegenerative Diseases.
Lasker~DeBakey Clinical Medical Research Award
An Interview with Alim Louis Benabid and Mahlon R. DeLong…
2014 Lasker Award honors Pr Alim Louis Benabid
NEWS RELEASE Alim Louis Benabid, Pioneer in Treatment of Parkinson’s Disease, Receives Lasker Foundation Award. Clinatec – The Edmond J. Safra Biomedical Research Center – Chairman Shares Top International Science Honor for Developing Deep Brain Stimulation Technique. GRENOBLE, France – Sept. 8, 2014 – Prof. Alim-Louis Benabid chairman of the board of Clinatec – […]
Project EXPLORER: clinical trials are currently underway
The first patients enrolled in the clinical trials have benefitted from non-invasive assessments using molecular imprinting, a new diagnostic tool. The Protool device captures key data concerning molecules, proteins, DNA, etc. from parts of the human body that were previously inaccessible.
Clinatec wins the 2014 Biovision Catalyzer Award
Clinatec was awarded the Biovision Catalyzer Prize for its “Silicomics”, and innovative technology that enables an early diagnosis and a targeted treatment of neurodegenerative diseases.